Carbapenem antibiotics such as imipenem, 2) panipenem 3) and meropenem 4) have been widely used for treatment of severe infectious diseases. These compounds have been developed for parenteral use, and no carbapenem has yet been used for the purpose of oral administration. Recently, orally active antibiotics with potent activity are of much interest in the clinical realm because oral administration with lower dosage is sometimes therapeutically advantageous. The title compound, CS-834 5) is now under clinical study as an oral antiinfective drug as are GV118819 6) and L-084. 7) CS-834 is a pivaloyloxymethyl (POM) ester-type prodrug of the active metabolite R-95867 that possesses a 1b-methylcarbapenem skeleton with a (R)-5-oxopyrrolidin-3-ylthio substituent at the C-2 position as shown in Chart 1 and exhibits highly potent antibacterial activity.
and meropenem 4) have been widely used for treatment of severe infectious diseases. These compounds have been developed for parenteral use, and no carbapenem has yet been used for the purpose of oral administration. Recently, orally active antibiotics with potent activity are of much interest in the clinical realm because oral administration with lower dosage is sometimes therapeutically advantageous. The title compound, CS-834 5) is now under clinical study as an oral antiinfective drug as are GV118819 6) and L-084. 7) CS-834 is a pivaloyloxymethyl (POM) ester-type prodrug of the active metabolite R-95867 that possesses a 1b-methylcarbapenem skeleton with a (R)-5-oxopyrrolidin-3-ylthio substituent at the C-2 position as shown in Chart 1 and exhibits highly potent antibacterial activity.
Synthesis of the active component, R-83201, which is a sodium salt of R-95867, was initially performed according to the conventional procedure developed by Merck researchers 8) starting from the carboxylic acid 1 9) via the reaction sequence 2→3→5→6 as shown in Chart 2.
5) The carboxy group of R-83201 thus obtained was esterified with POM iodide 10) in N,N-dimethylacetamide to give the POM ester, CS-834. In order to obtain CS-834 by a shorter route based on the Merck procedure, some attempts to provide the intermediate POM ester corresponding to the p-nitrobenzyl (PNB) ester 2 or 3 were tried, but all failed.
11) Then, our attention was focused on finding an alternative method for efficient synthesis of CS-834. One method we found was an intramol-ecular Wittig-type reaction developed at our laboratories for construction of the carbapenem skeleton. 12) In this paper, we wish to report a short-step synthesis of CS-834 by application of the procedure involving an intramolecular Wittig-type reaction in which the carboxy group is protected as a POM ester.
Results and Discussion
A new synthetic route to CS-834 based on the Wittig-type reaction for the construction of its skeleton is shown in Chart 3. Efficient synthesis of POM ester-type prodrugs, such as CS-834, is achieved by utilizing the POM group as a protecting group of carboxylic acid at an early stage of the synthesis.
We first tested the feasibility of the intramolecular Wittigtype reaction to construct the carbapenem skeleton with an oxopyrrolidinylthio moiety at the C-2 position using a PNB ester as the protecting group of the carboxylic acid (Chart 4). The thioester 7a was prepared by condensation of the acid 1 and the mercaptan 4 5) using N,N-carbonyldiimidazole (CDI) in acetonitrile (CH 3 CN) in 86% yield. Initial attempts to form the oxalimide 9a by treatment of 7a with 1 eq of p-nitrobenzyloxyoxalyl chloride in the presence of triethylamine (Et 3 N) resulted in formation of the undesired product 8. NOxalylation occurred only at the g-lactam of 7a, not at the blactam. Therefore, it was necessary to mask the NH group of the g-lactam before oxalylation. Selective N-silylation of the g-lactam ring and subsequent N-oxalylation of the b-lactam ring were successfully carried out as follows. The thioester 7a was treated with 1 eq of trimethylsilyl chloride (TMSCl) in the presence of Et 3 N in CH 2 Cl 2 at 0°C, followed by addition of 2.5 eq of p-nitrobenzyloxyoxalyl chloride at Ϫ20°C and then an aqueous workup to afford the desired product 9a in 73% yield. The oxalimide 9a was treated with 10 eq of triethyl phosphite in toluene at 60°C for 3 h under a nitrogen atmosphere to afford the ylide 10a. After removal of excess triethyl phosphite and solvent under reduced pressure, 10a was heated in mesitylene at 163°C for 8 h to give the desired compound 11a in 71% yield. Instead of triethyl phosphite, diethyl ethylphosphonite 13a,b) was examined for the cyclization of 9a. Formation of the ylide 10b easily occurred by treatment of 9a with 4 eq of diethyl ethylphosphonite at room temperature for 0.5 h, and subsequent cyclization of 10b to 11a was more readily achieved by heating in mesitylene at 163°C for 3 h in 81% yield.
From the above results, we were convinced that the Wittigtype reaction was utilizable for a more straightforward synthesis of CS-834. Thus, the tert-butyldimethylsilyl (TBS) group in 7a was exchanged via the alcohol 7b to the TMS or triethylsilyl (TES) group as in 7c or 7d with the intention of more easily deprotecting this group after construction of the carbapenem skeleton (Chart 5). Treatment of 7b with TMSCl and TESCl in the presence of Et 3 N in N,N-dimethylformamide (DMF) afforded 7c and 7d in 89% and 79% yield, respectively. [(Pivaloyloxy)methyloxy]oxalyl chloride (13) was prepared from oxalic acid in two steps as follows. 14) Treatment of oxalic acid with POM iodide in the presence of Et 3 N gave pivaloyloxymethyl oxalic acid mono-ester 12 as a crude oil. The unreacted oxalic acid and the crystalline by-product, bis(pivaloyloxymethyl) oxalate, were easily removed by washing with water and filtration, respectively. The acid 12 was treated with oxalyl chloroide in CH 2 Cl 2 to give the acid chloride 13. Selective oxalylation on the b-lactam ring of 7c to 9b using 13 was initially performed in a manner similar to that described for 9a. Reaction of 7c with 1 eq of TMSCl in the presence of Et 3 N in CH 2 Cl 2 at 0°C, followed by treatment with 3 eq of 13 at Ϫ20°C afforded 9b in 58% yield. The same reaction using TESCl instead of TMSCl gave the N-silylated oxalimide 9c in 58% yield. The N-TES bond in 9c was found to be stable during the usual aqueous workup and silica gel chromatography. In order to simplify the procedure to prepare 9b from the alcohol 7b, a one-pot synthesis was examined. Treatment of 7b with 2 equivalents of TMSCl in a mixed solvent of DMF and CH 2 Cl 2 , followed by addition of 13, provided 9b in 43% yield. The yield was, however, lower than the stepwise preparation (7b→7c→9b, 52%). We observed partial hydrolysis of the N-oxalyl bond of 9b and 9c during chromatography on silica gel, and this appears to be the reason for the relatively low isolated yields of 9b and 9c. On the other hand, the oxalimide 9d was stable on silica gel and prepared in a high yield (88% from 7d). The imide 9d possesses a relatively bulky substituent, a (triethylsilyloxy)ethyl group, at the C-3 position of the b-lactam ring, which might retard hydrolysis of the N-oxalyl bond and contribute to stabilization of the molecule.
With the oxalimides 9b-d in hand, we subjected them to the intramolecular Wittig-type reaction to construct the skeleton of CS-834. In a way similar to that described for cyclization of 9a to 11a, the oxalimides 9b-d were treated with 6 eq of triethyl phosphite in toluene at 60°C for 3 h under a nitrogen atmosphere to afford the corresponding triethoxy phosphorus ylides, whose heating in mesitylene at 163°C gave, contrary to our expectations, only the complex mixture. The functionality of the POM ester was found not to be stable under these reaction conditions when the ylide was derived from triethyl phosphite. After this, a more efficient reagent for the Wittig-type reaction, diethyl ethylphosphonite, was examined for the cyclization of 9b. Formation of the ylide 10c occurred easily by treating 9b with 3 eq of diethyl ethylphosphonite at room temperature for 0.5 h, and subsequent cyclization of 10c readily proceeded by heating in mesitylene at 163°C for 3 h to give 11b in 86% yield. Hydrolysis of 11b with 1 N HCl in CH 3 CN at 0°C for 5 min afforded a crude solid, which was recrystallized from ethyl acetate, to afford CS-834 in 88% yield. Oxalimides 9c and 9d, of which nitrogen atoms of the g-lactam rings are protected with a TES group, were similarly treated with diethyl ethylphosphonite, and the resulting ylides 10d and 10e were cyclized by heating to give the carbapenems 11c and 11e, respectively, which were accompanied by the respective Ndesilylated compounds 11b and 11d. These carbapenems were desilylated by treatment with 1 N HCl in CH 3 CN at 0°C to give the crude product, of which recrystallization afforded CS-834 in a pure form in 74% and 84% yield from the oxalimides 9c and 9d, respectively.
Conclusion
Application of the intramolecular Wittig-type reaction to the POM ester oxalimide intermediate enabled shortening of the synthetic route to CS-834 starting from the carboxylic acid 1 (45% overall yield in 6 steps), whereas the original route to CS-834 from 1 via 3 (as shown in Chart 2) required 8 steps and the overall yield was ca. 25%.
Experimental
Melting points are uncorrected.
1 H-NMR spectra were recorded on a JEOL JNM-EX-270 (270 MHz) spectrometer. Chemical shifts are shown in ppm downfield from internal tetramethylsilane in CDCl 3 or sodium 2,2-dimethyl-2-silapentane-5-sulfonate in D 2 O. The abbreviations used in 1 H-NMR data are as follows: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; dq, doublet of quartets; br, broad; m, multiplet. Infrared (IR) spectra were recorded on a JASCO A-102, FT/IR-8300 or FT/IR-8900 spectrometer. Optical rotations were measured on a Perkin-Elmer 141 spectrometer at 25°C. Mass spectra (MS) were obtained on a JEOL JMS-D300 or JMS-AX505H spectrometer. Chromatography columns were prepared with Silica gel 60 (230-400 mesh, E. Merck) or Cosmosil 75C 18 -PREP (Nacalai Tesque). Flash chromatography on silica gel was carried out using a Lobar ® pre-packed glass column Size A (LiChroprep ® Si60, E. Merck).
(3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-4-[(R)-1-[[(R)-2-oxopyrrolidin-4-ylthio]carbonyl]ethyl]-2-azetidinone (7a)
A suspension of 1 (1.04 g, 3.45 mmol) and CDI (567 mg, 3.50 mmol) in CH 3 CN (20 ml) was stirred at room temperature for 1 h. To the resulting clear solution was added a solution of 4 (404 mg, 3.45 mmol) in CH 3 CN (2 ml) at 0°C and the mixture was stirred at the same temperature for 15 h. After the solvent was removed under reduced pressure, the residue was dissolved in ethyl acetate, and the solution was washed successively with water, a saturated aqueous solution of sodium hydrogen carbonate and brine. The organic layer was dried over magnesium sulfate and filtered. After evaporation under reduced pressure, the residual crude product was purified by recrystallization from ethyl acetate-diisopropyl ether to give 7a (1.18 g, 86%) as colorless crystals, mp 139-141°C (dec. 
H 9 ). (3S,4S)-3-[(R)-1-Hydroxyethyl]-4-[(R)-1-[[(R)-2-oxopyrrolidin-4-ylthio]carbonyl]ethyl]-2-azetidinone (7b)
A solution of 7a (814 mg, 2.03 mmol) and boron trifluoride diethyl etherate (750 ml, 6.10 mmol) in CH 3 CN (15 ml) was stirred at room temperature for 3 h, and then quenched with a saturated aqueous solution of sodium hydrogen carbonate. After removal of the solvent under reduced pressure, the residue was subjected to reversed phase column chromatography on a Cosmosil 75C 18 -PREP (50 g) using a mixture of water and methanol (1 : 0 to 1 : 1) as the eluent. Collected fractions were concentrated under reduced pressure to give 7b (522 mg, 90%) as needles, mp 164-165°C (dec. Ϫ4 mol) in DMF (3 ml) was added Et 3 N (65 ml, 4.6ϫ 10 Ϫ4 mol) and TMSCl (59 ml, 4.6ϫ10 Ϫ4 mol) at 0°C, and the mixture was stirred at the same temperature for 2 h. After a saturated aqueous solution of sodium hydrogen carbonate was added to the mixture, the product was extracted with ethyl acetate. The extract was washed successively with a saturated aqueous solution of ammonium chloride, water and brine, and then dried over magnesium sulfate and concentrated under reduced pressure. The residue was subjected to flash chromatography on silica gel using a mixture of hexane, ethyl acetate and methanol (1 : 1 : 0→0 : 1 : 0→0 : 10 : 1) as the eluent to give 7c (73.1 mg, 89%) as colorless needles, mp 124°C (dec. 
Ϫ4 mol) and TESCl (77 ml, 4.6ϫ10 Ϫ4 mol) at 0°C, and the mixture was stirred at the same temperature for 1 h. After a saturated aqueous solution of sodium hydrogen carbonate was added to the mixture, the product was extracted with ethyl acetate. The extract was washed successively with a saturated aqueous solution of ammonium chloride, water and brine, and then dried over magnesium sulfate and concentrated under reduced pressure. The residue was subjected to flash chromatography on silica gel using a mixture of ethyl acetate and methanol (1 : 0 to 10 : 1) as the eluent to give 7d (133 mg, 79%) as colorless crystals, mp 139-141°C (dec. 2 Cl 2 (1.5 ml), and oxalyl chloride (0.13 ml, 1.5 mmol) and a catalytic amount of DMF (ca. 0.05 ml) were added at 0°C. This mixture was stirred at room temperature for 2 h, and concentrated under reduced pressure to give a crude 13 as a pale yellow oil (280 mg), which was immediately used without further purification for the next reaction. 1 
H-NMR (CDCl 3 ) d: 1.23 (9H, s), 5.94 (2H, s). (3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-1-[[( p-nitrobenzyl)oxy]oxalyl]-4-[(R)-1-[[(R)-2-oxopyrrolidin-4-ylthio]carbonyl]ethyl]-2-azetidinone (9a)
To a solution of 7a (220 mg, 5.50ϫ10
Ϫ4 mol) and Et 3 N (84 ml, 6.0ϫ10 Ϫ4 mol) in CH 2 Cl 2 (2 ml) was added TMSCl (76 ml, 6.0ϫ 10 Ϫ4 mol) at 0°C and the mixture was stirred at the same temperature for 10 min. After the reaction mixture was cooled at Ϫ20°C, Et 3 N (195 ml, 1.40 mmol) and a solution of p-nitrobenzyloxyoxalyl chloride (340 mg, 1.40 mmol) in CH 2 Cl 2 (1 ml) were added. After being stirred at Ϫ20°C for 20 min, a saturated aqueous solution of ammonium chloride was added to the reaction mixture and extracted with ethyl acetate. The extract was washed with a saturated aqueous solution of sodium hydrogen carbonate and brine, successively, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to flash chromatography on silica gel using a 1 : 2 mixture of hexane and ethyl acetate as the eluent, giving 9a (238 mg, 73%) as an amorphous solid. 1 
3S,4S)-4-[(R)-1-[[(R)-2-Oxopyrrolidin-4-ylthio]carbonyl]ethyl]-1-[[(pivaloyloxy)methyloxy]oxalyl]-3-[(R)-1-(trimethylsilyloxy)ethyl]-2-azetidinone (9b) To a solution of 7c (150 mg, 4.18ϫ10
Ϫ4 mol) and Et 3 N (60 ml, 4.3ϫ10 Ϫ4 mol) in CH 2 Cl 2 (1 ml) was added TMSCl (54 ml, 4.3ϫ 10 Ϫ4 mol) at 0°C and the mixture was stirred at the same temperature for 15 min. After the reaction mixture was cooled at Ϫ20°C, Et 3 N (180 ml, 1.29 mmol) and a solution of 13 (280 mg) in CH 2 Cl 2 (1 ml) were added to the reaction mixture. After being stirred at Ϫ20°C for 30 min, a saturated aqueous solution of ammonium chloride was added to the reaction mixture and extracted with ethyl acetate. The extract was washed successively with a saturated aqueous solution of sodium hydrogen carbonate and brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to flash chromatography on silica gel using a 1 : 2 mixture of hexane and ethyl acetate as the eluent, giving 9b (132 mg, 58%) as a colorless oil. 1 ( 1-(trimethylsilyloxy)ethyl]-2-azetidinone (9c) To a solution of 7c (150 mg, 4.18ϫ  10 Ϫ4 mol) and Et 3 N (60 ml, 4.3ϫ10 Ϫ4 mol) in CH 2 Cl 2 (1 ml) was added TESCl (73 ml, 4.3ϫ10
3S,4S)-4-[(R)-1-[[(R)-2-Oxo-1-(triethylsilyl)pyrrolidin-4-ylthio]carbonyl]ethyl]-1-[[[(pivaloyloxy)methyl]oxy]oxalyl]-3-[(R)-
Ϫ4 mol) at 0°C and the mixture was stirred at the same temperature for 15 min. After the reaction mixture was cooled at Ϫ20°C, Et 3 N (180 ml, 1.29 mmol) and a solution of 13 (280 mg) in CH 2 Cl 2 (1 ml) were added. After being stirred at Ϫ20°C for 30 min, a saturated aqueous solution of ammonium chloride was added to the reaction mixture and extracted with ethyl acetate. The extract was washed successively with a saturated aqueous solution of sodium hydrogen carbonate and brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to flash chromatography on silica gel using a 1 : 1 mixture of hexane and ethyl acetate as the eluent, giving 9c (160 mg, 58%) as a colorless oil. 1 (
3S,4S)-4-[(R)-1-[[(R)-2-Oxo-1-(triethylsilyl)pyrrolidin-4-ylthio]carbonyl]ethyl]-1-[[[(pivaloyloxy)methyl]oxy]oxalyl]-3-[(R)-1-(triethylsilyloxy)ethyl]-2-azetidinone (9d)
To a solution of 7d (170 mg, 4.24ϫ 10 Ϫ4 mol) and Et 3 N (63 ml, 4.5ϫ10 Ϫ4 mol) in CH 2 Cl 2 (1 ml) was added TESCl (75 ml, 4.5ϫ10 Ϫ4 mol) at 0°C and the mixture was stirred at the same temperature for 15 min. After the reaction mixture was cooled at Ϫ20°C, Et 3 N (180 ml, 1.29 mmol) and a solution of 13 (280 mg) in CH 2 Cl 2 (1 ml) were added. After being stirred at Ϫ20°C for 30 min, a saturated aqueous solution of ammonium chloride was added to the reaction mixture and extracted with ethyl acetate. The extract was washed successively with a saturated aqueous solution of sodium hydrogen carbonate and brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to column chromatography on silica gel using a 1 : 1 mixture of hexane and ethyl acetate as the eluent, giving 9d (261 mg, 88%) as a colorless oil. Ϫ5 mol) and triethyl phosphite (70 mg, 4.2ϫ10 Ϫ4 mol) in toluene (0.1 ml) was stirred at 60°C for 3 h under a nitrogen atmosphere. The mixture was concentrated under reduced pressure to give an oily residue, which was dissolved in mesitylene (5 ml), and refluxed for 8 h under a nitrogen atmosphere. After the solvent was removed in vacuo, the residue was subjected to column chromatography on silica gel (1 g) using ethyl acetate as the eluent to give 11a (17.2 mg, 71%) as a solid.
b) A solution of 9a (25.0 mg, 4.20ϫ10 Ϫ5 mol) and diethyl ethylphosphonite (purchased from Zeneca Inc., 25 mg, 1.7ϫ10 Ϫ4 mol) in toluene (0.3 ml) was stirred at room temperature for 0.5 h under a nitrogen atmosphere. The mixture was concentrated under reduced pressure to give an oily residue, which was dissolved in mesitylene (5 ml), and refluxed for 3 h under a nitrogen atmosphere. After the solvent was removed in vacuo, the residual crude product was purified by recrystallization from ethyl acetate-diisopropyl ether to give 11a (19.5 mg, 81%), mp 186-191°C (dec.) as pale yellow crystals. 1 Ϫ4 mol) in toluene (0.3 ml) was stirred at room temperature for 0.5 h under a nitrogen atmosphere. The mixture was concentrated under reduced pressure to give an oily residue, which was dissolved in mesitylene (5 ml), and refluxed for 3 h under a nitrogen atmosphere. After being cooled, the reaction mixture was passed through a short column of silica gel (500 mg) using a 10 : 1 mixture of ethyl acetate and methanol as the eluent. The eluate was concentrated under reduced pressure and left the crude product, which was purified by recrystallization from diisopropyl ether-hexane to give 11b (40.5 mg, 86%) as colorless crystals, mp 74-76°C (dec. Ϫ5 mol) in CH 3 CN (0.5 ml) was added 1 N HCl (70 ml) at 0°C. After stirring at 0°C for 5 min, the mixture was treated with a saturated aqueous solution of sodium hydrogen carbonate, and the product was extracted with CH 2 Cl 2 , dried over magnesium sulfate, and concentrated under reduced pressure. The crude product was purified by recrystallization from ethyl acetate to give CS-834 (26.5 mg, 88%) as colorless crystals, mp 188-190°C (dec.).
b) A solution of 9c (112 mg, 1.70ϫ10 Ϫ4 mol) and diethyl ethylphosphonite (75 mg, 5.0ϫ10 Ϫ4 mol) in toluene (0.5 ml) was stirred at room temperature for 30 min under a nitrogen atmosphere. The mixture was concentrated under reduced pressure to give an oily residue, which was dissolved in mesitylene (10 ml), and refluxed for 3 h under a nitrogen atmosphere. After being cooled, the reaction mixture was passed through a short column of silica gel (1 g) using a 10 : 1 mixture of ethyl acetate and methanol as the eluent. The eluate was concentrated under reduced pressure to give an oily residue, which was dissolved in CH 3 CN (1 ml), and 1 N HCl (0.3 ml) was added at 0°C. After stirring at 0°C for 30 min, the mixture was treated with a saturated aqueous solution of sodium hydrogen carbonate, and the product was extracted with CH 2 Cl 2 , dried over magnesium sulfate, and concentrated under reduced pressure. The crude product was purified by recrystallization from ethyl acetate to give CS-834 (62.9 mg, 84%) as colorless crystals, mp 188-190°C (dec.). c) A solution of 9d (94.5 mg, 1.35ϫ10 Ϫ4 mol) and diethyl ethylphosphonite (60 mg, 4.0ϫ10 Ϫ4 mol) in toluene (0.5 ml) was stirred at room temperature for 30 min under a nitrogen atmosphere. The mixture was concentrated under reduced pressure to give an oily residue, which was dissolved in mesitylene (10 ml), and refluxed for 3 h under a nitrogen atmosphere. After being cooled, the reaction mixture was passed through a short column of silica gel (1 g) using a 10 : 1 mixture of ethyl acetate and methanol as the eluent. The eluate was concentrated under reduced pressure to give an oily residue, which was dissolved in CH 3 CN (1 ml), and 1 N HCl (0.3 ml) was added at 0°C. After stirring at 0°C for 30 min, the mixture was treated with a saturated aqueous solution of sodium hydrogen carbonate, and the product was extracted with CH 2 Cl 2 , dried over magnesium sulfate, and concentrated under reduced pressure. The crude product was purified by recrystallization from ethyl acetate to give CS-834 (44.1 mg, 74%) as colorless crystals, mp 188-190°C (dec. 
